Sterling Capital Management LLC Lowers Position in Tenet Healthcare Corporation $THC

Sterling Capital Management LLC trimmed its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 34.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,008 shares of the company’s stock after selling 3,207 shares during the quarter. Sterling Capital Management LLC’s holdings in Tenet Healthcare were worth $1,134,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in THC. Aaron Wealth Advisors LLC raised its stake in shares of Tenet Healthcare by 10.3% during the 1st quarter. Aaron Wealth Advisors LLC now owns 1,670 shares of the company’s stock worth $315,000 after buying an additional 156 shares in the last quarter. Foster & Motley Inc. raised its position in Tenet Healthcare by 1.3% in the first quarter. Foster & Motley Inc. now owns 9,333 shares of the company’s stock worth $1,761,000 after acquiring an additional 118 shares in the last quarter. Louisiana State Employees Retirement System acquired a new stake in Tenet Healthcare in the first quarter valued at $4,812,000. Ritholtz Wealth Management boosted its position in shares of Tenet Healthcare by 1.2% during the 1st quarter. Ritholtz Wealth Management now owns 16,820 shares of the company’s stock worth $3,174,000 after purchasing an additional 194 shares in the last quarter. Finally, OP Asset Management Ltd acquired a new position in shares of Tenet Healthcare during the 1st quarter worth $49,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insider Transactions at Tenet Healthcare

In other news, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the sale, the director directly owned 24,805 shares in the company, valued at $4,399,166.75. The trade was a 10.79% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the transaction, the director directly owned 16,804 shares in the company, valued at $2,932,634.08. The trade was a 25.12% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare Stock Down 0.1%

THC stock opened at $186.90 on Wednesday. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. Tenet Healthcare Corporation has a 12 month low of $146.60 and a 12 month high of $247.21. The firm has a market capitalization of $16.10 billion, a PE ratio of 9.72, a P/E/G ratio of 1.54 and a beta of 1.28. The company’s 50 day simple moving average is $180.85 and its 200-day simple moving average is $197.27.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.Tenet Healthcare’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities analysts expect that Tenet Healthcare Corporation will post 17.61 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Morgan Stanley set a $254.00 price objective on shares of Tenet Healthcare in a report on Friday, May 1st. Wall Street Zen cut shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, May 11th. Barclays decreased their price target on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 5th. Mizuho raised their price objective on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a research note on Thursday, March 12th. Finally, Wells Fargo & Company decreased their target price on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Eighteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $244.32.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.